C2i & Hitachi To Collaborate On Automation Of Organoids Cell Culture & Mass Production of Exosomes

LATEST NEWS

C2i and HKUMed pioneers novel, needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes

08 May 2025 A research team led by the School of Public Health in the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in...

May 8

ARF4-mediated intracellular transport as a broad-spectrum antiviral target

The Centre for Immunology & Infection and the HKU-Pasteur Research Pole share a new study in Nature Microbiology t hat explores the...

Mar 28

[Hiring] IT Technician (Ref. C2i061)

Job Reference Number: C2i061 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the...

Mar 24

About

ABOUT C2i

The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.

C2i is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, two major institutions combining their expertise to establish this centre of excellence.